melanoma

Businessman jumping over hurdle - stock photo viafilmsGetty Images

BioNTech, Regeneron rack up response rate win for cancer vaccine

A combination of the cancer vaccine and Regeneron’s checkpoint inhibitor achieved a better response rate than a historical control in melanoma.

Nick Paul Taylor Jul 30, 2024 6:45am

plan B fail reroute road path trail miss

Merck halts phase 3 melanoma TIGIT trial due to discontinuations

May 13, 2024 8:39am

T-cells cancer cell attacking fight

AACR: Cancer vaccines get a reintroduction

Apr 10, 2024 4:30am

long shot miss basketball hoop fail shoot

Ultimovacs' cancer vaccine flunks another checkpoint combo test

Mar 7, 2024 6:14am

end of the road road block shut down closed blocked

Replimune shares halve as skin cancer drug fails phase 2

Dec 5, 2023 10:35am

layoff workforce cuts reduction stock

Kinnate lays off 70% of staff, pulls back from programs

Sep 19, 2023 6:00am